LTIP111A - The use of certain therapeutically imidazoles for manufacture of pharmaceutical preparations to be administered transdermally - Google Patents
The use of certain therapeutically imidazoles for manufacture of pharmaceutical preparations to be administered transdermallyInfo
- Publication number
- LTIP111A LTIP111A LTIP111A LTIP111A LTIP111A LT IP111 A LTIP111 A LT IP111A LT IP111 A LTIP111 A LT IP111A LT IP111 A LTIP111 A LT IP111A LT IP111 A LTIP111 A LT IP111A
- Authority
- LT
- Lithuania
- Prior art keywords
- pct
- imidazoles
- manufacture
- pharmaceutical preparations
- administered transdermally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
PCT No. PCT/FI92/00166 Sec. 371 Date Nov. 12, 1993 Sec. 102(e) Date Nov. 12, 1993 PCT Filed May 27, 1992 PCT Pub. No. WO92/21334 PCT Pub. Date Dec. 10, 1992.This invention relates to a transdermal preparation comprising a therapeutically active compound of the formula: <IMAGE> (I) or <IMAGE> (II) where R1, R2, and R3, which can be the same or different are H, CH3, C2H5 or Cl; X is CH=CH or (CH2)n where n is 1 to 3 or X is -C(OR5)H- where R5 is methyl or ethyl; and R4 is hydrogen or a straight alkyl of 1 to 4 carbon atoms. The transdermal administration of the compounds can be accomplished by preparations in the form of ointments, emulsions, lotions, solutions, creams or transdermal patches.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9111773A GB2256135B (en) | 1991-05-31 | 1991-05-31 | Transdermal administration of 4-substituted imidazoles |
Publications (2)
Publication Number | Publication Date |
---|---|
LTIP111A true LTIP111A (en) | 1994-03-25 |
LT3005B LT3005B (en) | 1994-08-25 |
Family
ID=10695905
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTIP111A LT3005B (en) | 1991-05-31 | 1992-05-29 | The use of certain therapeutically imidazoles for manufacture of pharmaceutical preparations to be administered transdermally. |
Country Status (18)
Country | Link |
---|---|
US (1) | US5464628A (en) |
EP (1) | EP0586467B1 (en) |
JP (1) | JP3269822B2 (en) |
AT (1) | ATE199317T1 (en) |
AU (1) | AU1780892A (en) |
CA (1) | CA2110162C (en) |
DE (1) | DE69231709T2 (en) |
DK (1) | DK0586467T3 (en) |
EE (1) | EE02994B1 (en) |
ES (1) | ES2154636T3 (en) |
FI (1) | FI935350A (en) |
GB (1) | GB2256135B (en) |
GR (1) | GR3035499T3 (en) |
IE (1) | IE66188B1 (en) |
LT (1) | LT3005B (en) |
LV (1) | LV10042B (en) |
NO (1) | NO307365B1 (en) |
WO (1) | WO1992021334A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997006788A1 (en) * | 1995-08-14 | 1997-02-27 | Janssen Pharmaceutica N.V. | Transdermal administration of vorozole |
US5891461A (en) * | 1995-09-14 | 1999-04-06 | Cygnus, Inc. | Transdermal administration of olanzapine |
US5807570A (en) * | 1995-09-29 | 1998-09-15 | Cygnus, Inc. | Transdermal administration of ropinirole and analogs thereof |
GB9614098D0 (en) | 1996-07-05 | 1996-09-04 | Orion Yhtymae Oy | Transdermal delivery of levosimendan |
DE19820151A1 (en) * | 1998-05-06 | 1999-11-11 | Hexal Ag | Transdermal therapeutic system for the application of candesartan |
TW200930291A (en) | 2002-04-29 | 2009-07-16 | Bayer Cropscience Ag | Pesticidal heterocycles |
FI20041425A0 (en) * | 2004-11-05 | 2004-11-05 | Orion Corp | Transmucosal veterinary composition |
ES2536478T3 (en) * | 2004-12-15 | 2015-05-25 | Teikoku Seiyaku Co., Ltd. | External patches containing ethofenamate |
ES2338716T3 (en) | 2006-01-27 | 2010-05-11 | F.Hoffmann-La Roche Ag | USE OF 4-IMIDAZOL DERIVATIVES FOR CNS DISORDERS. |
CA2659379A1 (en) * | 2006-08-08 | 2008-02-14 | Intervet International B.V. | Composition for enhanced antiparasitic activity |
US7795263B2 (en) * | 2008-07-08 | 2010-09-14 | Wildlife Laboratories, Inc. | Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals |
US20210323929A1 (en) * | 2018-07-18 | 2021-10-21 | Clexio Biosciences Ltd. | Purified Detomidine, Process of Preparing and Methods of Use |
WO2020222188A1 (en) | 2019-05-01 | 2020-11-05 | Clexio Biosciences Ltd. | Methods of treating pruritus |
CN112220767B (en) * | 2020-09-25 | 2022-10-25 | 安徽省公众检验研究院有限公司 | Preparation method of altimezole hydrochloride sustained-release tablet |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU518569B2 (en) * | 1979-08-07 | 1981-10-08 | Farmos-Yhtyma Oy | 4-benzyl- and 4-benzoyl imidazole derivatives |
GB2069481B (en) * | 1980-02-13 | 1983-07-27 | Farmos Oy | Substituted imidazole derivatives |
GB2101114B (en) * | 1981-07-10 | 1985-05-22 | Farmos Group Ltd | Substituted imidazole derivatives and their preparation and use |
GB2167408B (en) | 1984-11-23 | 1988-05-25 | Farmos Oy | Substituted imidazole derivatives and their preparation and use |
US4672344A (en) | 1985-04-19 | 1987-06-09 | Siemens Aktiengesellschaft | Polarized electromagnetic relay |
FI864570A0 (en) | 1986-11-11 | 1986-11-11 | Farmos Oy | THERAPEUTIC ANVAENDBAR FOERENING. |
US5124157A (en) * | 1989-08-18 | 1992-06-23 | Cygnus Therapeutic Systems | Method and device for administering dexmedetomidine transdermally |
FI894911A0 (en) * | 1989-10-17 | 1989-10-17 | Farmos Oy | EN TERAPEUTISKT VAERDEFULL FOERENING. |
US5304569A (en) * | 1989-11-13 | 1994-04-19 | Orion-Yhtyma Oy | Compositions and their use in lowering intraocular pressure |
-
1991
- 1991-05-31 GB GB9111773A patent/GB2256135B/en not_active Revoked
-
1992
- 1992-05-27 DE DE69231709T patent/DE69231709T2/en not_active Expired - Fee Related
- 1992-05-27 ES ES92910941T patent/ES2154636T3/en not_active Expired - Lifetime
- 1992-05-27 AT AT92910941T patent/ATE199317T1/en not_active IP Right Cessation
- 1992-05-27 CA CA002110162A patent/CA2110162C/en not_active Expired - Fee Related
- 1992-05-27 JP JP50981692A patent/JP3269822B2/en not_active Expired - Fee Related
- 1992-05-27 WO PCT/FI1992/000166 patent/WO1992021334A1/en active IP Right Grant
- 1992-05-27 US US08/146,203 patent/US5464628A/en not_active Expired - Fee Related
- 1992-05-27 EP EP92910941A patent/EP0586467B1/en not_active Expired - Lifetime
- 1992-05-27 DK DK92910941T patent/DK0586467T3/en active
- 1992-05-27 AU AU17808/92A patent/AU1780892A/en not_active Abandoned
- 1992-05-28 LV LVP-92-19A patent/LV10042B/en unknown
- 1992-05-29 LT LTIP111A patent/LT3005B/en not_active IP Right Cessation
- 1992-07-01 IE IE921938A patent/IE66188B1/en not_active IP Right Cessation
-
1993
- 1993-11-25 NO NO934261A patent/NO307365B1/en unknown
- 1993-11-30 FI FI935350A patent/FI935350A/en unknown
-
1994
- 1994-10-18 EE EE9400271A patent/EE02994B1/en not_active IP Right Cessation
-
2001
- 2001-03-01 GR GR20010400329T patent/GR3035499T3/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB9111773D0 (en) | 1991-07-24 |
NO307365B1 (en) | 2000-03-27 |
JPH06507618A (en) | 1994-09-01 |
FI935350A0 (en) | 1993-11-30 |
DE69231709T2 (en) | 2001-10-04 |
ATE199317T1 (en) | 2001-03-15 |
US5464628A (en) | 1995-11-07 |
NO934261D0 (en) | 1993-11-25 |
IE66188B1 (en) | 1995-12-13 |
EP0586467B1 (en) | 2001-02-28 |
ES2154636T3 (en) | 2001-04-16 |
FI935350A (en) | 1993-11-30 |
CA2110162A1 (en) | 1992-12-10 |
EP0586467A1 (en) | 1994-03-16 |
CA2110162C (en) | 2002-11-12 |
IE921938A1 (en) | 1992-12-02 |
NO934261L (en) | 1993-11-25 |
WO1992021334A1 (en) | 1992-12-10 |
GB2256135B (en) | 1995-01-18 |
LT3005B (en) | 1994-08-25 |
LV10042B (en) | 1995-02-20 |
JP3269822B2 (en) | 2002-04-02 |
LV10042A (en) | 1994-05-10 |
AU1780892A (en) | 1993-01-08 |
GB2256135A (en) | 1992-12-02 |
DK0586467T3 (en) | 2001-03-26 |
DE69231709D1 (en) | 2001-04-05 |
GR3035499T3 (en) | 2001-06-29 |
EE02994B1 (en) | 1997-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTIP111A (en) | The use of certain therapeutically imidazoles for manufacture of pharmaceutical preparations to be administered transdermally | |
KR890701562A (en) | Immunomodulatory Azas Pirans | |
ES8107185A1 (en) | Piperidine derivatives, their preparation and pharmaceutical compositions containing them. | |
HUP0001170A2 (en) | Pharmaceutical compositions containing benzimidazole-2-carbamate derivatives as active ingredients for the treatment of viral infections and cancer | |
PH16535A (en) | 3,5 substituted phenylbutyl-substituted amino ethanol derivatives,their compositions and their use | |
ES8501410A1 (en) | Phospholipid derivatives, processes for preparation thereof and pharmaceutical composition of the same. | |
ES8800145A1 (en) | Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same. | |
KR910009259A (en) | Pyrimidone derivatives and homologues for the treatment of asthma or certain skin diseases | |
KR920021534A (en) | Leukotriene B_4 Antagonist | |
FI104071B (en) | Analogous Process for the Preparation of Therapeutically Useful 2,5-Dihydro-2,5-Dioxo-1H-Benzene-β-Azepine Derivatives | |
ES8601850A1 (en) | (1-Arylcyclobutyl) alkylamine derivatives, their preparation and their use as therapeutic agents. | |
KR880000432A (en) | 4 (3H) -oxo-5,6,7,8-tetrahydropyrido-2,3-d pyrimidine derivative | |
KR930019212A (en) | Phisostigmine derivatives and uses thereof and pharmaceutical preparations containing them | |
HUP0001050A2 (en) | Amino acid ester containing azole antifungals, process for their preparation, pharmaceuticals containing the same and intermediates | |
AU687023B2 (en) | Use of idazoxan and derivatives thereof in preparing a drug for treating parkinson's disease and its development | |
KR970704723A (en) | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents (DIHYDROBENZOFURAN AND RELATED COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS) | |
MY104540A (en) | Pharmaceutical preparations. | |
IE39679L (en) | Methods and compositions for killing parasites of warm¹blooded animals | |
ES479440A1 (en) | Ethanolamine compounds, processes for their preparation, pharmaceutical preparations containing them and their medicinal use. | |
KR950702830A (en) | METHODS OF TREATING PSORIASIS EMPLOYING SUBSTITUTED AZASPIRANES | |
BE899918A (en) | CARBOXYLIC ACID AMIDES AND DERIVATIVES THEREOF, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF. | |
MX9709833A (en) | Use of benzimidazoles for the manufacture of a medicament for the treatment of leukemia. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM9A | Lapsed patents |
Effective date: 20060529 |